Significant increase of glucose transport activity in breast cancer

Chinese Journal of Pathology

Volumn 37, Issue 2, 2008, Pages 103-108

  Li, Juan ^a   Yang, Shou Jing ^a   Zhao, Xi Long ^a   Zhang, Ya Qing ^a   Li, Kai Nan ^a   Cui, Ji Hong ^a   Li, Jing ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Breast diseases; Breast neoplasms; Diagnosis; Monosaccharide transport proteins; Prognosis

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 1; MESSENGER RNA; GLUCOSE TRANSPORTER;

ACINAR CELL; ARTICLE; BREAST; BREAST ADENOMA; BREAST ADENOSIS; BREAST CANCER; BREAST CARCINOMA; BREAST FIBROADENOMA; BREAST LESION; CANCER DIAGNOSIS; CYTOPLASM; EN VISION METHOD; FEMALE; GLUCOSE TRANSPORT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING; BREAST TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PAGET NIPPLE DISEASE; PHYSIOLOGY; PROGNOSIS;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; PROGNOSIS;

EID: 41849086305     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Joost HG, Thorens B. The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review). Mol Membr Biol, 2001, 18(4):247-256.
2. Mueckler M, Caruso C, Baldwin SA, et al. Sequence and structure of a human glucose transporter. Science, 1985, 229(4717):941-945.
3. Shows TB, Eddy RL, Byers MG, et al. Polymorphic human glucose transporter gene (GLUT) is on chromosome 1p31.3 - p35. Diabetes, 1987, 36(4):546-549.
4. van Baardwijk A, Dooms C, van Suylen RJ, et al. The maximum uptake of (18) F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1 alpha and GLUT-1 in non-small cell lung cancer. Eur J Cancer, 2007, 43(9):1392-1398.
5. Sun HC, Qiu ZJ, Liu J, et al. Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis. Int J Oncol, 2007, 30(6):1359-1367.
6. Horróe N, van Diest PJ, van der Groep P, et al. Hypoxia and angiogenesis in endometrioid endometrial carcinogenesis. Cell Oncol, 2007, 29(3):219-227.
7. Oliver RJ, Woodwards RT, Sloan P, et al. Prognostic value of facilitative glucose transporter Glut-1 in oral squamous cell carcinomas treated by surgical resection; results of EORTC Translational Research Fund studies. Eur J Cancer, 2004, 40(4):503-507.
8. Sakashita M, Aoyama N, Minami R, et al. Glut1 expression in T1 and T2 stage colorectal carcinomas: its relationship to clinicopathological features. Eur J Cancer, 2001, 37(2):204-209.
9. Griffiths EA, Pritchard SA, Welch IM, et al. Is the hypoxia-inducible factor pathway important in gastric cancer? Eur J Cancer, 2005, 41(18):2792-2805.
10. Cantuaria G, Magalhaes A, Penalver M, et al. Expression of GLUT-1 glucose transporter in borderline and malignant epithelial tumors of the ovary. Gynecol Oncol, 2000, 79(1):33-37.
11. Kunkel M, Reichert TE, Benz P, et al. Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer, 2003, 97(4):1015-1024.
12. De Schutter H, Barbé B, Spaepen M, et al. Microsatellite alterations in head and neck squamous cell carcinoma and relation to expression of pimonidazole, CA IX and GLUT-1. Radiother Oncol, 2006, 80(2):143-150.
13. Evans A, Bates V, Troy H, et al. Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies. Cancer Chemother Pharmacol, 2008, 61(3):377-393.
14. Alò PL, Visca P, Botti C, et al. Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue. Am J Clin Pathol, 2001, 116(1):129-134.
15. Grover-McKay M, Walsh SA, Seftor EA, et al. Role for glucose transporter 1 protein in human breast cancer. Pathol Oncol Res, 1998, 4(2):115-120.
16. Hoskin PJ, Sibtain A, Daley FM, et al. GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON. Br J Cancer, 2003, 89(7):1290-1297.
17. Lund EL, Høg A, Olsen MW, et al. Differential regulation of VEGF, HIF1 alpha and angiopoietin-1, -2 and -4 by hypoxia and ionizing radiation in human glioblastoma. Int J Cancer, 2004, 108(6):833-838.
18. Cooper R, Sarioǧlu S, Sökmen S, et al. Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma? Br J Cancer, 2003, 89(5):870-876.
19. Gu J, Yamamoto H, Fukunaga H, et al. Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D- glucose uptake by positron emission tomography in colorectal cancer. Dig Dis Sci, 2006, 51(12):2198-2205.
20. Kitagawa T, Tanaka M, Akamatsu Y. Regulation of glucose transport activity and expression of glucose transporter mRNA by serum, growth factors and phorbol ester in quiescent mouse fibroblasts. Biochim Biophys Acta, 1989, 980(1):100-108.
21. Kitagawa T, Masumi A, Akamatsu Y. Transforming growth factor-beta 1 stimulates glucose uptake and the expression of glucose transporter mRNA in quiescent Swiss mouse 3T3 cells. J Biol Chem, 1991, 266(27):18066-18071.
22. Klip A, Tsakiridis T, Marette A, et al. Regulation of expression of glucose transporters by glucose: a review of studies in vivo and in cell cultures. FASEB J, 1994, 8(1):43-53.
23. Bos R, van Der Hoeven JJ, van Der Wall E, et al. Biologic correlates of (18) fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. J Clin Oncol, 2002, 20(2):379-387.
24. Airley R, Loncaster J, Davidson S, et al. Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clin Cancer Res, 2001, 7(4):928-934.
25. Kang SS, Chun YK, Hur MH, et al. Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma. Jpn J Cancer Res, 2002, 93(10):1123-1128.
26. Haber RS, Rathan A, Weiser KR, et al. GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis. Cancer, 1998, 83(1):34-40.
27. Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev, 2007, 26(2):225-239.